News
Milestones, funding and progress on our way to the clinic.
NBank Capital Invests €500,000 in InhalPlus
InhalPlus secures its first external investor: NBank Capital is investing €500,000 in InhalPlus GmbH.
InhalPlus GmbH Founded as a Spin-off of Fraunhofer ITEM
InhalPlus GmbH was founded in Hannover on August 27, 2026, as a spin-off of Fraunhofer ITEM and uses the Fraunhofer patent portfolio under an exclusive license.
InhalPlus Receives €2.8 Million in Non-Dilutive Funding
This week we received both official grant notifications: €2.8 million in non-dilutive funding is now secured. We are proud and grateful to […]